NLARx Newsletter Header
NLARx News
September 27, 2010
In This Issue
NLARx News
Upcoming Conference
In the States
Outrage of the Week
Advertising & Marketing
Pharma Watch
Our Neighbors to the North
PBM Watch
Pricing
Patents & Generics
Medicare & Medicaid
Safety & Clinical Trials
Conflicts of Interest
NLARx on Facebook
Quick Links
Join Our Mailing List
NLARx  in the News
NLARx Signs on to Letter to USTR on Pharmaceutical Pricing Chapter in TPP Negotiations more
Upcoming Conference
2010 International Symposium on Safe Medicine's Unused Drug Return Conference, Portland, Maine, October 10-12 more
News from the States
Connecticut: Connecticut Doctors Slow to Adopt Electronic Record-Keeping more
Florida: Bid dispute may delay Florida's prescription drug monitoring plan more
Mississippi: Cuts Threaten Medicine Access for Mentally Ill more
Oregon: Effect of Drug Sample Removal on Prescribing in a Family Practice Clinic more
Outrage of the Week
PBM Group Spent $552K on Lobbying in 2Q more
Advertising and Marketing
U.S. Joins Whistleblower Suit Against Pfizer For Drug Marketing more
The ROI of Reporters: Are Journalists the New Target of Pharma Largesse? more
Pharma, Facebook, and Inappropriate Ads more
Forest, Maker of Celexa, to Pay More Than $313 Million to Settle Marketing Case more
Communication -- Is It Healthcare? more
Pharma Watch
Are Secret Drug Recalls Common? more
FDA Cites BMS on PR Plant Offenses more
From Botox To Acuvail: Allergan Violates Another Law more
Permission Slip Medicine more
America's Most Popular Mind Medicines more
Our Neighbors to the North
Nova Scotia Seeks Cheaper Prescription Drugs more
Ontario Leads the Way on Drug Cost Reform more
PBM Watch
Express Scripts Ready to Do Another PBM Deal more
Ahead of the Bell: Growth Expected in PBM Sector more
CVS Caremark Seen as Top Benefit Manager more
Drug Prices and Reimbursement 
Bristol-Myers To Pay $27M For Illegal Pricing more
Should Medical Studies Include Cost Information? more
NEJM: Pay Attention to Drugs' Cost-Effectiveness more
Patents and Generics
Senate Republicans Hate The Pay-To-Delay Ban more
CBO Finds Generic Drugs Save Medicare $33 Billion In 2007 more
Medicare and Medicaid
Premium Rates May Skyrocket For Many Medicare Drug Plans more
Report: Drug Costs for Seniors to Skyrocket Next Year more
Dodging a Medicare Mishap more
Medicare Confronts Issues With Prescription Drug Program And Medical Equipment Purchases more
New CMS chief to focus on Quality, Organization and Costs more
House Passes Fraud Bill To Keep Executives Associated With Wrongdoing From Future Medicare Business more
Efforts to Combat Medicare Fraud Draw Mixed Signals from Indies, PBMs more
Safety and Clinical Trials
How Large is the Counterfeit Drugs Problem? more
The FDA's Conflict of Interest -- Firms Pay the Bills more
The House Approves Legislation Related To The Disposal Of Unused Prescription Drugs more
FDA, European Regulators, Restrict Avandia Use more
Drug Shortages Are Causing Safety Problems: Survey more
A Wave of Addiction and Crime, with the Medicine Cabinet to Blame more
What's In the Discussion Draft of the New Drug Safety Bill? more
Counterfeit Drugs Become Growing Problem more
FDA, European Regulators, Restrict Avandia Use more
Amgen Recalls Some Procrit, Epogen more
Google Sues 'Rogue' Pharmacies more
Conflict of Interest, CME, and Academic Detailing
In Stepping up COI Rules, Yale Takes 'Rational' Approach to Industry more
Some Docs Believe They Deserve Dinners And Gifts more
Study: Medical Residents' Attitudes Towards Gifts Easily Swayed more
Harvard Neurologist Starts New Program For Doctor Education more
New Med-Ed Firm Says No to Industry Funding more
Device Docs Don't Disclose Conflicts of Interest more
Subscribe to the NLARx Blog and Join us on Facebook!
For up-to-the-minute posting of news of interest and events, become a fan of NLARx on Facebook here and subscribe to our Blog.